Earli
Earli is a biotech company using AI-designed genetic switches for early cancer detection and treatment. Its synthetic-biomarker technology forces cancer cells to reveal themselves for earlier, more accurate detection, and can program cancer cells to self-destruct while sparing healthy tissue. Founded by Cyriac Roeding and backed by a16z and Menlo Ventures, Earli is a research-stage company with no public developer platform, API, or SDK surface. This profile was added to the API Evangelist network as a venture-portfolio lead awaiting further enrichment.
Earli is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Healthcare, Cancer Detection, and Diagnostics.
Earli’s developer surface includes engineering blog and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API